Georgia Keresty

Georgia Keresty is currently an Independent Director at Commissioning Agents, Inc. since 2018, at Intellia Therapeutics, Inc. since 2021, and at Solid Biosciences, Inc. since 2021.
Former roles include Independent Director at AspenTech Corp.
from 2019 to 2022, Director at Janssen Alzheimer Immunotherapy, The New Jersey Foundation For Aging, and Aspen Technology, Inc., Vice President-Worldwide Quantity & Compliance at Bristol Myers Squibb Co. from 1999 to 2003, Trustee at Clarkson University, Head-Manufacturing Site at Novartis Pharmaceuticals Corp.
from 1983 to 1997, Chief Operating Officer-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. from 2017 to 2020, and Chief Operating Officer at Volnay Therapeutics LLC from 2023 to 2024.
Education includes graduate studies at the University of Southern California and Pace University, undergraduate studies at Clarkson University and Ramapo College of New Jersey, and an MBA and a doctorate from Rutgers State University of New Jersey.